FLAW 发表于 2025-3-21 19:18:56

书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0642455<br><br>        <br><br>书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0642455<br><br>        <br><br>

彩色的蜡笔 发表于 2025-3-21 20:49:01

http://reply.papertrans.cn/65/6425/642455/642455_2.png

expdient 发表于 2025-3-22 01:30:30

http://reply.papertrans.cn/65/6425/642455/642455_3.png

MODE 发表于 2025-3-22 08:32:38

https://doi.org/10.1007/978-2-8178-0492-7Akt; cancer; mTOR; rapamycin; Molecular

Jingoism 发表于 2025-3-22 10:50:11

http://reply.papertrans.cn/65/6425/642455/642455_5.png

FILTH 发表于 2025-3-22 13:50:35

Monica Mita,Alain Mita,Eric K. RowinskyFirst book on that topic.Input and perspectives by international leaders?.Preclinical and clinical data available on the subject have been integrated.A dedicated chapter on toxicity profile of mTOR in

Simulate 发表于 2025-3-22 19:37:43

http://reply.papertrans.cn/65/6425/642455/642455_7.png

鸵鸟 发表于 2025-3-23 01:05:21

mTOR Inhibition for Cancer Therapy: Past, Present and Future978-2-8178-0492-7

lobster 发表于 2025-3-23 01:51:49

Book 2016 already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation. .

奇怪 发表于 2025-3-23 06:28:40

http://reply.papertrans.cn/65/6425/642455/642455_10.png
页: [1] 2 3 4
查看完整版本: Titlebook: mTOR Inhibition for Cancer Therapy: Past, Present and Future; Monica Mita,Alain Mita,Eric K. Rowinsky Book 2016 Springer-Verlag France 201